White House withdraws Heidi Overton’s FDA nomination after Trump pick received bipartisan pushback
The withdrawal followed bipartisan concerns over her vaccine and abortion views, leaving the agency without a permanent leader.
- On Tuesday, The White House withdrew Heidi Overton's nomination to lead the Food and Drug Administration after determining she lacked sufficient Senate support.
- Her nomination faced bipartisan resistance in Congress, alongside criticism from Antiabortion forces and supporters of Health Secretary Robert Kennedy's Make America Healthy Again movement.
- Previously expressing "strong concerns," Republican Sen. Bill Cassidy of Louisiana, chairman of the Senate Health and Pensions Committee, called Overton's role "almost disqualifying."
- Officials stated the White House intends to "go in a new direction at FDA" while continuing to support Kennedy's health agenda, necessitating a new candidate search.
- Since Marty Makary's resignation in May, the agency has operated under acting Commissioner Kyle Diamantas, leaving the administration to identify a replacement to lead the FDA.
112 Articles
112 Articles
US President Donald Trump withdrew Heidi Overton's candidacy for the management of the Food and Drug Administration (FDA) due to insufficient congressional support, according to three people familiar with the situation, who spoke to Reuters on Tuesday.
The White House is backing away from its pick to run the FDA, withdrawing Dr. Heidi Overton's appointment after clear signs she washed the Republican votes needed to advance in the Senate. Overton, a top domestic policy official, had faced GOP design over her work leasing vape rules, her push...
WHITE HOUSE PULLS HEIDI OVERTON'S FDA NOMINATION HOURS BEFORE KEY SENATE VOTE
The White House withdrew Dr. Heidi Overton's nomination to lead the FDA on Tuesday, one day before a Senate health committee vote, after Republicans on the panel signaled they would not support her.
Trump withdraws Heidi Overton as nominee to lead Food and Drug Administration, sources say
US President Donald Trump has withdrawn the nomination of Heidi Overton to lead the Food and Drug Administration due to insufficient support in Congress.
Ex-Nvidia CEO Jensen Huang says before US Congress in December +++ Trump meets three-way summit allies in Asia +++ US President expects to catch up with rare earths +++ The newsblog.
Trump pulls Overton from consideration for FDA Commissioner
The Trump Administration has pulled Heidi Overton from consideration as FDA Commissioner amid reports that she would not have enough votes to gain approval by a Senate committee tomorrow. In recent days Senate Health Education, Labor and Pensions Committee Chairman Sen. Bill Cassidy, R-LA, said he and other GOP
Coverage Details
Bias Distribution
- 69% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium

































